ClinicalTrials.Veeva

Menu

Combined Method for Induction of Labor

W

Woman's Health University Hospital, Egypt

Status and phase

Unknown
Phase 2

Conditions

Induced Labor

Treatments

Device: Foley's catheter
Drug: Misoprostol ( Prostaglandin E2)

Study type

Interventional

Funder types

Other

Identifiers

NCT02685085
FM0702116

Details and patient eligibility

About

Induction of labor is performed via the vaginal misorostol 25 ug/ 6 hours and intracervical foley's cather administration and both techniques performed together.

Enrollment

300 estimated patients

Sex

Female

Ages

18 to 45 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • females presenting for induction of labor

Exclusion criteria

  • previous cesarean section
  • previous uterine scars e.g. myomectomy
  • refusal to participate in the study

Trial design

300 participants in 3 patient groups

Misoprostol
Experimental group
Description:
in this group misoprostol 25 ug will be administrated for induction of labor every 6 hours
Treatment:
Drug: Misoprostol ( Prostaglandin E2)
Foley's catheter
Experimental group
Description:
In this group foley's catheter 30 cc will be used for induction of labor
Treatment:
Device: Foley's catheter
Combined
Experimental group
Description:
Both misoprostol 25 ug and foley's catheter will be used for induction
Treatment:
Drug: Misoprostol ( Prostaglandin E2)
Device: Foley's catheter

Trial contacts and locations

1

Loading...

Central trial contact

Dina MR Dakhly, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems